Do analysts prefer NTWK or ADVB?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NetSol Technologies 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Advanced Biomed 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media prefer NTWK or ADVB?

In the previous week, NetSol Technologies had 1 more articles in the media than Advanced Biomed. MarketBeat recorded 2 mentions for NetSol Technologies and 1 mentions for Advanced Biomed. Advanced Biomed's average media sentiment score of 0.75 beat NetSol Technologies' score of 0.71 indicating that Advanced Biomed is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NetSol Technologies 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Advanced Biomed 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer ADVB or YHNA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Advanced Biomed 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 YHN Acquisition I 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings & valuation, ADVB or YHNA?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Advanced Biomed N/A N/A -$3.26M $4.82 1.64 YHN Acquisition I N/A N/A N/A N/A N/A

Is ADVB or YHNA more profitable?

Advanced Biomed's return on equity of 87.74% beat YHN Acquisition I's return on equity. Company Net Margins Return on Equity Return on Assets Advanced Biomed N/A 87.74% 64.49% YHN Acquisition I N/A N/A N/A

Does the media refer more to ADVB or YHNA?

In the previous week, Advanced Biomed and Advanced Biomed both had 1 articles in the media. Advanced Biomed's average media sentiment score of 0.75 beat YHN Acquisition I's score of 0.00 indicating that Advanced Biomed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Advanced Biomed 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive YHN Acquisition I 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer PHUN or ADVB?

Phunware presently has a consensus price target of $2.00, indicating a potential downside of 1.96%. Given Phunware's stronger consensus rating and higher possible upside, equities research analysts plainly believe Phunware is more favorable than Advanced Biomed. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Phunware 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Advanced Biomed 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media refer more to PHUN or ADVB?

In the previous week, Phunware had 4 more articles in the media than Advanced Biomed. MarketBeat recorded 5 mentions for Phunware and 1 mentions for Advanced Biomed. Advanced Biomed's average media sentiment score of 0.75 beat Phunware's score of -0.47 indicating that Advanced Biomed is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Phunware 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Advanced Biomed 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend PXLW or ADVB?

Pixelworks currently has a consensus price target of $15.00, indicating a potential upside of 132.56%. Given Pixelworks' stronger consensus rating and higher possible upside, analysts clearly believe Pixelworks is more favorable than Advanced Biomed. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pixelworks 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Advanced Biomed 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is PXLW or ADVB more profitable?

Advanced Biomed's return on equity of 87.74% beat Pixelworks' return on equity. Company Net Margins Return on Equity Return on Assets Pixelworks N/A -47.19% -12.88% Advanced Biomed N/A 87.74% 64.49%

Does the media prefer PXLW or ADVB?

In the previous week, Pixelworks had 1 more articles in the media than Advanced Biomed. MarketBeat recorded 2 mentions for Pixelworks and 1 mentions for Advanced Biomed. Advanced Biomed's average media sentiment score of 0.75 beat Pixelworks' score of 0.00 indicating that Advanced Biomed is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pixelworks 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Advanced Biomed 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer ADVB or ARBK?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Advanced Biomed 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Argo Blockchain 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Is ADVB or ARBK more profitable?

Advanced Biomed's return on equity of 87.74% beat Argo Blockchain's return on equity. Company Net Margins Return on Equity Return on Assets Advanced Biomed N/A 87.74% 64.49% Argo Blockchain N/A N/A N/A

Advanced Biomed (ADVB) Competitors

$7.91 +1.54 (+24.18%)

As of 04:00 PM Eastern

Compare

ADVB vs. NTWK, YHNA, PHUN, PXLW, and ARBK

Should you buy Advanced Biomed stock or one of its competitors? Advanced Biomed's main competitors and comparable companies include NetSol Technologies (NTWK), YHN Acquisition I (YHNA), Phunware (PHUN), Pixelworks (PXLW), and Argo Blockchain (ARBK). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "application software" industry.

How does Advanced Biomed compare to NetSol Technologies?

NetSol Technologies (NASDAQ:NTWK) and Advanced Biomed (NASDAQ:ADVB) are both small-cap technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, media sentiment, profitability and valuation.

16.0% of NetSol Technologies shares are owned by institutional investors. 13.5% of NetSol Technologies shares are owned by company insiders. Comparatively, 27.0% of Advanced Biomed shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

NetSol Technologies has a beta of 0.93, meaning that its stock price is 7% less volatile than the broader market. Comparatively, Advanced Biomed has a beta of -0.41, meaning that its stock price is 141% less volatile than the broader market.

In the previous week, NetSol Technologies had 1 more articles in the media than Advanced Biomed. MarketBeat recorded 2 mentions for NetSol Technologies and 1 mentions for Advanced Biomed. Advanced Biomed's average media sentiment score of 0.75 beat NetSol Technologies' score of 0.71 indicating that Advanced Biomed is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NetSol Technologies	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Advanced Biomed	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

NetSol Technologies has a net margin of 2.49% compared to Advanced Biomed's net margin of 0.00%. Advanced Biomed's return on equity of 87.74% beat NetSol Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NetSol Technologies	2.49%	4.24%	2.76%
Advanced Biomed	N/A	87.74%	64.49%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NetSol Technologies	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Advanced Biomed	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

NetSol Technologies has higher revenue and earnings than Advanced Biomed. Advanced Biomed is trading at a lower price-to-earnings ratio than NetSol Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NetSol Technologies	$66.09M	0.76	$2.92M	$0.15	28.33
Advanced Biomed	N/A	N/A	-$3.26M	$4.82	1.64

Summary

NetSol Technologies beats Advanced Biomed on 8 of the 13 factors compared between the two stocks.

How does Advanced Biomed compare to YHN Acquisition I?

Advanced Biomed (NASDAQ:ADVB) and YHN Acquisition I (NASDAQ:YHNA) are both small-cap technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, institutional ownership, profitability, valuation, dividends, earnings and risk.

Advanced Biomed's return on equity of 87.74% beat YHN Acquisition I's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Advanced Biomed	N/A	87.74%	64.49%
YHN Acquisition I	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Advanced Biomed	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
YHN Acquisition I	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Advanced Biomed has a beta of -0.41, meaning that its share price is 141% less volatile than the broader market. Comparatively, YHN Acquisition I has a beta of 0.01, meaning that its share price is 99% less volatile than the broader market.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Advanced Biomed	N/A	N/A	-$3.26M	$4.82	1.64
YHN Acquisition I	N/A	N/A	N/A	N/A	N/A

In the previous week, Advanced Biomed and Advanced Biomed both had 1 articles in the media. Advanced Biomed's average media sentiment score of 0.75 beat YHN Acquisition I's score of 0.00 indicating that Advanced Biomed is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Advanced Biomed	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
YHN Acquisition I	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Advanced Biomed beats YHN Acquisition I on 3 of the 4 factors compared between the two stocks.

How does Advanced Biomed compare to Phunware?

Phunware (NASDAQ:PHUN) and Advanced Biomed (NASDAQ:ADVB) are both small-cap technology companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, media sentiment, analyst recommendations, risk, institutional ownership, profitability and earnings.

Advanced Biomed has a net margin of 0.00% compared to Phunware's net margin of -471.72%. Advanced Biomed's return on equity of 87.74% beat Phunware's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Phunware	-471.72%	-13.52%	-11.93%
Advanced Biomed	N/A	87.74%	64.49%

Phunware has a beta of 2.61, suggesting that its stock price is 161% more volatile than the broader market. Comparatively, Advanced Biomed has a beta of -0.41, suggesting that its stock price is 141% less volatile than the broader market.

Phunware presently has a consensus price target of $2.00, indicating a potential downside of 1.96%. Given Phunware's stronger consensus rating and higher possible upside, equities research analysts plainly believe Phunware is more favorable than Advanced Biomed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Phunware	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Advanced Biomed	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Advanced Biomed has lower revenue, but higher earnings than Phunware. Phunware is trading at a lower price-to-earnings ratio than Advanced Biomed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Phunware	$2.55M	16.36	-$11.40M	-$0.65	N/A
Advanced Biomed	N/A	N/A	-$3.26M	$4.82	1.64

In the previous week, Phunware had 4 more articles in the media than Advanced Biomed. MarketBeat recorded 5 mentions for Phunware and 1 mentions for Advanced Biomed. Advanced Biomed's average media sentiment score of 0.75 beat Phunware's score of -0.47 indicating that Advanced Biomed is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Phunware	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Advanced Biomed	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

7.6% of Phunware shares are owned by institutional investors. 0.2% of Phunware shares are owned by company insiders. Comparatively, 27.0% of Advanced Biomed shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Advanced Biomed beats Phunware on 8 of the 14 factors compared between the two stocks.

How does Advanced Biomed compare to Pixelworks?

Pixelworks (NASDAQ:PXLW) and Advanced Biomed (NASDAQ:ADVB) are both small-cap technology companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment.

Pixelworks currently has a consensus price target of $15.00, indicating a potential upside of 132.56%. Given Pixelworks' stronger consensus rating and higher possible upside, analysts clearly believe Pixelworks is more favorable than Advanced Biomed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pixelworks	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Advanced Biomed	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Advanced Biomed has lower revenue, but higher earnings than Pixelworks. Pixelworks is trading at a lower price-to-earnings ratio than Advanced Biomed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pixelworks	$1.14M	36.03	-$22.50M	-$2.34	N/A
Advanced Biomed	N/A	N/A	-$3.26M	$4.82	1.64

In the previous week, Pixelworks had 1 more articles in the media than Advanced Biomed. MarketBeat recorded 2 mentions for Pixelworks and 1 mentions for Advanced Biomed. Advanced Biomed's average media sentiment score of 0.75 beat Pixelworks' score of 0.00 indicating that Advanced Biomed is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pixelworks	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Advanced Biomed	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

21.4% of Pixelworks shares are owned by institutional investors. 4.7% of Pixelworks shares are owned by insiders. Comparatively, 27.0% of Advanced Biomed shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Pixelworks has a beta of 1.75, suggesting that its share price is 75% more volatile than the broader market. Comparatively, Advanced Biomed has a beta of -0.41, suggesting that its share price is 141% less volatile than the broader market.

Advanced Biomed's return on equity of 87.74% beat Pixelworks' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pixelworks	N/A	-47.19%	-12.88%
Advanced Biomed	N/A	87.74%	64.49%

Summary

Pixelworks and Advanced Biomed tied by winning 7 of the 14 factors compared between the two stocks.

How does Advanced Biomed compare to Argo Blockchain?

Advanced Biomed (NASDAQ:ADVB) and Argo Blockchain (NASDAQ:ARBK) are both small-cap technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership, media sentiment and dividends.

Advanced Biomed's return on equity of 87.74% beat Argo Blockchain's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Advanced Biomed	N/A	87.74%	64.49%
Argo Blockchain	N/A	N/A	N/A

Argo Blockchain has higher revenue and earnings than Advanced Biomed. Argo Blockchain is trading at a lower price-to-earnings ratio than Advanced Biomed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Advanced Biomed	N/A	N/A	-$3.26M	$4.82	1.64
Argo Blockchain	$15.52M	2.46	$5.08M	-$117.39	N/A

Advanced Biomed has a beta of -0.41, suggesting that its stock price is 141% less volatile than the broader market. Comparatively, Argo Blockchain has a beta of 1.9, suggesting that its stock price is 90% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Advanced Biomed	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Argo Blockchain	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

2.4% of Argo Blockchain shares are held by institutional investors. 27.0% of Advanced Biomed shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Advanced Biomed had 1 more articles in the media than Argo Blockchain. MarketBeat recorded 1 mentions for Advanced Biomed and 0 mentions for Argo Blockchain. Advanced Biomed's average media sentiment score of 0.75 beat Argo Blockchain's score of 0.00 indicating that Advanced Biomed is being referred to more favorably in the media.

Company	Overall Sentiment
Advanced Biomed	Positive
Argo Blockchain	Neutral

Summary

Advanced Biomed beats Argo Blockchain on 7 of the 12 factors compared between the two stocks.

Get Advanced Biomed News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ADVB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ADVB vs. The Competition

Export

Metric	Advanced Biomed	Software Industry	Technology Sector	NASDAQ Exchange
Market Cap	$13.05M	$15.93B	$29.61B	$12.95B
Dividend Yield	N/A	3.42%	2.73%	10.20%
P/E Ratio	1.64	127.02	74.94	24.73
Price / Sales	N/A	1,295.02	596.25	108.63
Price / Cash	N/A	43.91	50.51	37.44
Price / Book	2.46	8.51	8.15	6.42
Net Income	-$3.26M	$437.06M	$679.00M	$347.12M
7 Day Performance	3.94%	2.31%	3.04%	2.48%
1 Month Performance	53.29%	1.94%	0.18%	-1.04%
1 Year Performance	N/A	8.70%	201.34%	23.22%

Advanced Biomed Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ADVB Advanced Biomed	1.551 of 5 stars	$7.91 +24.2%	N/A	N/A	$13.05M	N/A	1.64	40	Gap Down
NTWK NetSol Technologies	2.0757 of 5 stars	$4.28 -1.6%	N/A	+4.4%	$51.66M	$66.09M	28.54	1,460
YHNA YHN Acquisition I	0.4324 of 5 stars	$10.94 +0.0%	N/A	+5.1%	$46.89M	N/A	N/A	N/A	High Trading Volume
PHUN Phunware	0.9869 of 5 stars	$2.24 +2.8%	$2.00 -10.7%	-17.4%	$44.58M	$2.55M	N/A	120	Earnings Report Upcoming Earnings Analyst Downgrade
PXLW Pixelworks	1.6523 of 5 stars	$6.38 +2.2%	$15.00 +135.1%	-28.5%	$39.71M	$690K	N/A	220	News Coverage Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ADVB) was last updated on 8/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Advanced Biomed (ADVB) Competitors

ADVB vs. NTWK, YHNA, PHUN, PXLW, and ARBK

How does Advanced Biomed compare to NetSol Technologies?

Summary

How does Advanced Biomed compare to YHN Acquisition I?

Summary

How does Advanced Biomed compare to Phunware?

Summary

How does Advanced Biomed compare to Pixelworks?

Summary

How does Advanced Biomed compare to Argo Blockchain?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ADVB vs. The Competition

Advanced Biomed Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Advanced Biomed (ADVB) Competitors

ADVB vs. NTWK, YHNA, PHUN, PXLW, and ARBK

How does Advanced Biomed compare to NetSol Technologies?

Do insiders and institutionals have more ownership in NTWK or ADVB?

Which has more volatility & risk, NTWK or ADVB?

Does the media prefer NTWK or ADVB?

Is NTWK or ADVB more profitable?

Do analysts prefer NTWK or ADVB?

Which has stronger valuation & earnings, NTWK or ADVB?

Summary

How does Advanced Biomed compare to YHN Acquisition I?

Is ADVB or YHNA more profitable?

Do analysts prefer ADVB or YHNA?

Which has more volatility and risk, ADVB or YHNA?

Which has better earnings & valuation, ADVB or YHNA?

Does the media refer more to ADVB or YHNA?

Summary

How does Advanced Biomed compare to Phunware?

Is PHUN or ADVB more profitable?

Which has more risk and volatility, PHUN or ADVB?

Do analysts prefer PHUN or ADVB?

Which has preferable earnings & valuation, PHUN or ADVB?

Does the media refer more to PHUN or ADVB?

Do insiders & institutionals hold more shares of PHUN or ADVB?

Summary

How does Advanced Biomed compare to Pixelworks?

Do analysts recommend PXLW or ADVB?

Which has higher earnings & valuation, PXLW or ADVB?

Does the media prefer PXLW or ADVB?

Do institutionals & insiders believe in PXLW or ADVB?

Which has more risk and volatility, PXLW or ADVB?

Is PXLW or ADVB more profitable?

Summary

How does Advanced Biomed compare to Argo Blockchain?

Is ADVB or ARBK more profitable?

Which has stronger valuation and earnings, ADVB or ARBK?

Which has more volatility & risk, ADVB or ARBK?

Do analysts prefer ADVB or ARBK?

Do insiders and institutionals believe in ADVB or ARBK?

Does the media favor ADVB or ARBK?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ADVB vs. The Competition

Advanced Biomed Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools